Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1972 Jul;25(7):654–655. doi: 10.1136/jcp.25.7.654

Clinical experience with brinase.

E P Frisch
PMCID: PMC477472  PMID: 5070274

Full text

PDF
653

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. AMBRUS C. M., MARKUS G. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme. Am J Physiol. 1960 Sep;199:491–494. doi: 10.1152/ajplegacy.1960.199.3.491. [DOI] [PubMed] [Google Scholar]
  3. ASTRUP T., MULLERTZ S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952 Oct;40(2):346–351. doi: 10.1016/0003-9861(52)90121-5. [DOI] [PubMed] [Google Scholar]
  4. ASTRUP T., NISSEN U. URINARY TRYPSIN INHIBITOR (MINGIN): TRANSFORMATION INTO A NEW TRYPSIN INHIBITOR BY ACID HYDROLYSIS OR BY SIALIDASE. Nature. 1964 Jul 18;203:255–257. doi: 10.1038/203255a0. [DOI] [PubMed] [Google Scholar]
  5. Arocha-Piñango C. L. Fibrinolisis producida por contacto con orugas: comunicación prelininar. Acta Cient Venez. 1967;18(5):136–139. [PubMed] [Google Scholar]
  6. Arocha-Piñango C. L., Layrisse M. Fibrinolysis produced by contact with a caterpillar. Lancet. 1969 Apr 19;1(7599):810–812. doi: 10.1016/s0140-6736(69)92070-4. [DOI] [PubMed] [Google Scholar]
  7. Astrup T. Comparative studies of some antifibrinolytic agents and proteinase inhibitors. Ann N Y Acad Sci. 1968 Jun 28;146(2):601–611. doi: 10.1111/j.1749-6632.1968.tb20318.x. [DOI] [PubMed] [Google Scholar]
  8. BARTLETT R. C. Rapid cellulose acetate electrophoresis. I. Serum proteins. Clin Chem. 1963 Jun;9:317–324. [PubMed] [Google Scholar]
  9. BERGKVIST R., SVAERD P. O. STUDIES ON THE THROMBOLYTIC ACTIVITY OF A PROTEASE FROM ASPERGILLUS ORYZAE. Acta Physiol Scand. 1964 Apr;60:363–371. doi: 10.1111/j.1748-1716.1964.tb02899.x. [DOI] [PubMed] [Google Scholar]
  10. BRAKMAN P., ASTRUP T. SELECTIVE INHIBITION IN HUMAN PREGNANCY BLOOD OF UROKINASE INDUCED FIBRINOLYSIS. Scand J Clin Lab Invest. 1963;15:603–609. doi: 10.3109/00365516309051342. [DOI] [PubMed] [Google Scholar]
  11. Beller F. K., Mitchell P. S., Gorstein F. Fibrin deposition in the ribbit kidney produced by protease inhibitors. Thromb Diath Haemorrh. 1967 May 31;17(3-4):427–439. [PubMed] [Google Scholar]
  12. Bennett N. B. A method for the quantitative assay of inhibitor of plasminogen activation in human serum. Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):12–22. [PubMed] [Google Scholar]
  13. Bennett N. B., Ogston C. M., McAndrew G. M., Ogston D. Studies on the fibrinolytic enzyme system in obesity. J Clin Pathol. 1966 May;19(3):241–243. doi: 10.1136/jcp.19.3.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bennett N. B., Ogston C. M., Ogston D. The effect of prolonged exercise on the components of the blood fibrinolytic enzyme system. J Physiol. 1968 Sep;198(2):479–485. doi: 10.1113/jphysiol.1968.sp008618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bonnar J., Davidson J. F., Pidgeon C. F., McNicol G. P., Douglas A. S. Fibrin degradation products in normal and abnormal pregnancy and parturition. Br Med J. 1969 Jul 19;3(5663):137–140. doi: 10.1136/bmj.3.5663.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bonnar J., McNicol G. P. Douglas AS: The behaviour of the coagulation and fibrinolytic mechanisms in abruptio placentae. J Obstet Gynaecol Br Commonw. 1969 Sep;76(9):799–805. doi: 10.1111/j.1471-0528.1969.tb06181.x. [DOI] [PubMed] [Google Scholar]
  17. Bonnar J., McNicol G. P., Douglas A. S. Coagulation and fibrinolytic mechanisms during and after normal childbirth. Br Med J. 1970 Apr 25;2(5703):200–203. doi: 10.1136/bmj.2.5703.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bonnar J., McNicol G. P., Douglas A. S. Fibrinolytic enzyme system and pregnancy. Br Med J. 1969 Aug 16;3(5667):387–389. doi: 10.1136/bmj.3.5667.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Bonnar J., Prentice C. R., McNicol G. P., Douglas A. S. Haemostatic mechanism in the uterine circulation during placental separation. Br Med J. 1970 Jun 6;2(5709):564–567. doi: 10.1136/bmj.2.5709.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Brakman P., Mohler E. R., Jr, Astrup T. A group of patients with impaired plasma fibrinolytic system and selective inhibition of tissue activator-induced fibrinolysis. Scand J Haematol. 1966;3(5):389–398. doi: 10.1111/j.1600-0609.1966.tb02382.x. [DOI] [PubMed] [Google Scholar]
  21. Bygdeman S. Effect of an Aspergillus enzyme on adenosinediphosphate (ADP) induced platelet aggregation and adhesiveness. Life Sci. 1967 Mar 1;6(5):499–505. doi: 10.1016/0024-3205(67)90053-7. [DOI] [PubMed] [Google Scholar]
  22. COCCHERI S., BORGATTI E., LORETI A., GENNARI P. IL SIGNIFICATO DELLA FIBRINOLISI NELL'ATEROGENESI SPERIMENTALE DA DIETA IPERCOLESTEROLICA. I. EFFETTI DI UNA ALIMENTAZIONE RICCA DI INIBITORE FIBRINOLITICO. G Clin Med. 1964 Dec;45:1434–1452. [PubMed] [Google Scholar]
  23. Cash J. D., Allan A. G. The fibrinolytic response to moderate exercise and intravenous adrenaline in the same subjects. Br J Haematol. 1967 May;13(3):376–383. doi: 10.1111/j.1365-2141.1967.tb08752.x. [DOI] [PubMed] [Google Scholar]
  24. Cash J. D. Effect of moderate exercise on the fibrinolytic system in normal young men and women. Br Med J. 1966 Aug 27;2(5512):502–506. doi: 10.1136/bmj.2.5512.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Cash J. D., Woodfield D. G. Fibrinolytic response to moderate exercise in 50 healthy middle-aged subjects. Br Med J. 1968 Jun 15;2(5606):658–661. doi: 10.1136/bmj.2.5606.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Cash J. D., Woodfield D. G. Fibrinolytic response to moderate, exhaustive and prolonged exercise in normal subjects. Nature. 1967 Aug 5;215(5101):628–629. doi: 10.1038/215628a0. [DOI] [PubMed] [Google Scholar]
  27. Chait A., Summers D., Krasnow N., Wechsler B. M. Observations on the fate of large pulmonary emboli. Am J Roentgenol Radium Ther Nucl Med. 1967 Jun;100(2):364–373. doi: 10.2214/ajr.100.2.364. [DOI] [PubMed] [Google Scholar]
  28. Coccheri S., Ollendorff P., Astrup T. Sensitivity of pregnant mice to intravenous tissue thromboplastin. Thromb Diath Haemorrh. 1969 Aug 31;22(1):35–44. [PubMed] [Google Scholar]
  29. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  30. Dioguardi N., Lotto A., Levi G. F., Rota M., Proto C., Mannucci P. M., Rossi P., Lomanto B., Mattei G., Fiorelli G. Controlled trial of streptokinase and heparin in acute myocardial infarction. Lancet. 1971 Oct 23;2(7730):891–895. doi: 10.1016/s0140-6736(71)92501-3. [DOI] [PubMed] [Google Scholar]
  31. Ehringer H., Fischer M. Erfolgreiche thrombolytische Therapie bei subakuten arteriellen Thrombosen. Vorläufiger Bericht. Med Welt. 1968 Aug 10;32:1726–passim. [PubMed] [Google Scholar]
  32. Ekelund H., Hedner U., Nilsson I. M. Fibrinolysis in newborns. Acta Paediatr Scand. 1970 Jan;59(1):33–43. doi: 10.1111/j.1651-2227.1970.tb15511.x. [DOI] [PubMed] [Google Scholar]
  33. FLETCHER A. P., ALKJAERSIG N., SHERRY S., GENTON E., HIRSH J., BACHMANN F. THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION. J Lab Clin Med. 1965 May;65:713–731. [PubMed] [Google Scholar]
  34. FOGARTY T. J., CRANLEY J. J., KRAUSE R. J., STRASSER E. S., HAFNER C. D. A method for extraction of arterial emboli and thrombi. Surg Gynecol Obstet. 1963 Feb;116:241–244. [PubMed] [Google Scholar]
  35. Fearnley G. R., Chakrabarti R., Evans J. F. Effect of ethyloestrenol combined with phenformin or with metformin on platelet stickiness and serum-cholesterol in patients with occlusive vascular disease. Lancet. 1968 Nov 9;2(7576):1004–1007. doi: 10.1016/s0140-6736(68)91297-x. [DOI] [PubMed] [Google Scholar]
  36. Fearnley G. R., Chakrabarti R., Hocking E. D. Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease. Lancet. 1967 Nov 11;2(7524):1008–1011. doi: 10.1016/s0140-6736(67)90286-3. [DOI] [PubMed] [Google Scholar]
  37. Fletcher A. P., Alkjaersig N., O'Brien J., Tulevski V. G. Blood hypercoagulability and thrombosis. Trans Assoc Am Physicians. 1970;83:159–167. [PubMed] [Google Scholar]
  38. Fred H. L., Axelrad M. A., Lewis J. M., Alexander J. K. Rapid resolution of pulmonary thromboemboli in man. An angiographic study. JAMA. 1966 Jun 27;196(13):1137–1139. [PubMed] [Google Scholar]
  39. Freedman H. J., Roschlau W. H. Some factors influencing the toxicity of thromobolytic enzymes (Brinase). Can J Physiol Pharmacol. 1970 Jan;48(1):69–76. doi: 10.1139/y70-011. [DOI] [PubMed] [Google Scholar]
  40. Ganrot P. O., Niléhn J. E. Immunochemical determination of human plasminogen. Clin Chim Acta. 1968 Nov;22(3):335–340. doi: 10.1016/0009-8981(68)90033-8. [DOI] [PubMed] [Google Scholar]
  41. Gottlob R., Blümel G., Piza F., Brücke R., Böhmig H. J. Studies on thrombolysis with streptokinase. II. The influence of changes due to age in thrombi and whole blood clots. Thromb Diath Haemorrh. 1968 Jul 31;19(3):516–525. [PubMed] [Google Scholar]
  42. Green J. R. Note on the Action of Sodium Chloride in dissolving Fibrin. J Physiol. 1887 Dec;8(6):372–377. doi: 10.1113/jphysiol.1887.sp000265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Hedin S. G. On the presence of a proteolytic enzyme in the normal serum of the ox. J Physiol. 1903 Nov 2;30(2):195–201. doi: 10.1113/jphysiol.1903.sp000989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Hedner U., Nilsson I. M., Jacobsen C. D. Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity. Scand J Clin Lab Invest. 1970 Jun;25(4):329–336. doi: 10.3109/00365517009046213. [DOI] [PubMed] [Google Scholar]
  45. Hender U., Nilsson I. M., Robertson B. Determination of plasminogen in clots and thrombi. Thromb Diath Haemorrh. 1966 Jul 31;16(1):38–50. [PubMed] [Google Scholar]
  46. Hirsh J., Hale G. S., McDonald I. G., McCarthy R. A., Pitt A. Streptokinase therapy in acute major pulmonary embolism: effectiveness and problems. Br Med J. 1968 Dec 21;4(5633):729–734. doi: 10.1136/bmj.4.5633.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. IATRIDIS S. G., FERGUSON J. H. Effect of physical exercise on blood clotting and fibrinolysis. J Appl Physiol. 1963 Mar;18:337–344. doi: 10.1152/jappl.1963.18.2.337. [DOI] [PubMed] [Google Scholar]
  48. Isacson S., Nilsson I. M. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems. Scand J Haematol. 1970;7(5):404–408. doi: 10.1111/j.1600-0609.1970.tb01922.x. [DOI] [PubMed] [Google Scholar]
  49. James K., Taylor F. B., Jr, Fudenberg H. H. The effect of alpha-2-macroglobulin in human serum on trypsin, plasmin, and thrombin activities. Biochim Biophys Acta. 1967 Feb 21;133(2):374–376. doi: 10.1016/0005-2795(67)90080-3. [DOI] [PubMed] [Google Scholar]
  50. Johnson A. J., Kline D. L., Alkjaersig N. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968. Thromb Diath Haemorrh. 1969 Apr 30;21(2):259–272. [PubMed] [Google Scholar]
  51. KOHN J. A cellulose acetate supporting medium for zone electrophoresis. Clin Chim Acta. 1957 Aug;2(4):297–303. doi: 10.1016/0009-8981(57)90005-0. [DOI] [PubMed] [Google Scholar]
  52. Kakkar V. V., Flanc C., Howe C. T., O'Shea M., Flute P. T. Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin. Br Med J. 1969 Mar 29;1(5647):806–810. doi: 10.1136/bmj.1.5647.806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. LAURELL C. B. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. Anal Biochem. 1965 Feb;10:358–361. doi: 10.1016/0003-2697(65)90278-2. [DOI] [PubMed] [Google Scholar]
  54. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  55. Lauritsen O. S. Urokinase inhibitor in human plasma. Scand J Clin Lab Invest. 1968 Dec;22(4):314–321. doi: 10.3109/00365516809167068. [DOI] [PubMed] [Google Scholar]
  56. MCNICOL G. P., BAIN W. H., WALKER F., RIFKIND B. M., DOUGLAS A. S. THROMBOLYSIS STUDIED IN AN ARTIFICIAL CIRCULATION: THROMBI PREPARED IN VITRO IN A CHANDLER'S TUBE. Lancet. 1965 Apr 17;1(7390):838–842. doi: 10.1016/s0140-6736(65)91375-9. [DOI] [PubMed] [Google Scholar]
  57. MCNICOL G. P., DOUGLAS A. S. STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT. Br Med J. 1965 May 1;1(5443):1149–1153. doi: 10.1136/bmj.1.5443.1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. MULLERTZ S. The action of plasmin on fibrin and fibrinogen in blood. Acta Physiol Scand. 1953 Mar 31;28(1):29–40. doi: 10.1111/j.1748-1716.1953.tb00957.x. [DOI] [PubMed] [Google Scholar]
  59. MacKay N., Ferguson J. C., McNicol G. P. Effects of the venom of the rhinoceros horned viper (Bitis nasicornis) on blood coagulation, platelet aggregation, and fibrinolysis. J Clin Pathol. 1970 Dec;23(9):789–796. doi: 10.1136/jcp.23.9.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Miller G. A., Gibson R. V., Honey M., Sutton G. C. Treatment of pulmonary embolism with streptokinase. A preliminary report. Br Med J. 1969 Mar 29;1(5647):812–815. doi: 10.1136/bmj.1.5647.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. NILSSON I. M., KROOK H., STERNBY N. H., SODERBERG E., SODERSTROM N. Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta Med Scand. 1961 Mar;169:323–337. doi: 10.1111/j.0954-6820.1961.tb07838.x. [DOI] [PubMed] [Google Scholar]
  62. OGSTON D., MCANDREW G. M. FIBRINOLYSIS IN OBESITY. Lancet. 1964 Dec 5;2(7371):1205–1207. doi: 10.1016/s0140-6736(64)91042-6. [DOI] [PubMed] [Google Scholar]
  63. Ogston D., Ogston C. M., Fullerton H. W. The plasminogen content of thrombi. Thromb Diath Haemorrh. 1966 Jan 31;15(1):220–230. [PubMed] [Google Scholar]
  64. Ogston D., Ogston C. M., Ratnoff O. D., Forbes C. D. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest. 1969 Oct;48(10):1786–1801. doi: 10.1172/JCI106145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. PARASKEVAS M., NILSSON I. M., MARTINSSON G. A method for determining serum inhibitors of plasminogen activation. Scand J Clin Lab Invest. 1962;14:138–144. doi: 10.3109/00365516209079685. [DOI] [PubMed] [Google Scholar]
  66. PARFENTJEV I. A., JOHNSON M. L., CLIFFTON E. E. The determination of plasma fibrinogen by turbidity with ammonium sulfate. Arch Biochem Biophys. 1953 Oct;46(2):470–480. doi: 10.1016/0003-9861(53)90218-5. [DOI] [PubMed] [Google Scholar]
  67. POULAIN M., RENARD M. J., JOSSO F. ESSAI D'APPR'ECIATION STATISTIQUE DE L'ACTION PR'EVENTIVE DE L'ACIDE EPSILON-AMINO-CAPROUIQUE SUR LES COMPLICATIONS H'EMORRAGIQUES DE L'H'EMOPHILIE. Hemostase. 1964 Jul-Sep;4:307–309. [PubMed] [Google Scholar]
  68. Pandolfi M., Isacson S., Nilsson I. M. Low fibrinolytic activity in the walls of veins in patients with thrombosis. Acta Med Scand. 1969 Jul-Aug;186(1-2):1–5. doi: 10.1111/j.0954-6820.1969.tb01431.x. [DOI] [PubMed] [Google Scholar]
  69. Pandolfi M., Nilsson I. M., Robertson B., Isacson S. Fibrinolytic activity of human veins. Lancet. 1967 Jul 15;2(7507):127–128. doi: 10.1016/s0140-6736(67)92964-9. [DOI] [PubMed] [Google Scholar]
  70. Pandolfi M., Robertson B., Isacson S., Nilsson I. M. Fibrinolytic activity of human veins in arms and legs. Thromb Diath Haemorrh. 1968 Nov 15;20(1):247–256. [PubMed] [Google Scholar]
  71. Poliwoda H., Alexander K., Buhl V., Holsten D., Wagner H. H. Treatment of chronic arterial occlusions with streptokinase. N Engl J Med. 1969 Mar 27;280(13):689–692. doi: 10.1056/NEJM196903272801304. [DOI] [PubMed] [Google Scholar]
  72. REID W. O., HOLBURN R. R., DESIPIN M. T., TOCANTINS L. M. THE ROLE OF FIBRINOLYSIN AND PROFIBRINOLYSIN ACTIVATOR IN HEMOPHILIA. Am J Med Sci. 1965 May;249:518–533. doi: 10.1097/00000441-196505000-00005. [DOI] [PubMed] [Google Scholar]
  73. ROSCHLAU W. H. THE EVALUATION IN THE DOG OF A PROTEOLYTIC ENZYME DERIVED FROM ASPERGILLUS ORYZAE. Can J Physiol Pharmacol. 1964 Jan;42:109–125. doi: 10.1139/y64-013. [DOI] [PubMed] [Google Scholar]
  74. Reid W. O., Hodge S. M., Cerutti E. R. The use of EACA in preventing or reducing hemorrhages in the hemophiliac. Thromb Diath Haemorrh. 1967 Aug 15;18(1-2):179–189. [PubMed] [Google Scholar]
  75. Ritz N. D. Fibrinolytic activity in hemophilia and the use of epsilon-aminocaproic acid. N Y State J Med. 1965 Dec 1;65(23):2914–2925. [PubMed] [Google Scholar]
  76. Roschlau W. H., Fisher A. M. Thrombolytic therapy with local perfusions of CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Angiology. 1966 Sep;17(9):670–682. doi: 10.1177/000331976601700906. [DOI] [PubMed] [Google Scholar]
  77. Roschlau W. H. Thrombolytic therapy with CA-7, a fibrinolytic enzyme from Aspergillus oryzae: a report of two representative cases. Can Med Assoc J. 1968 Apr 20;98(16):757–761. [PMC free article] [PubMed] [Google Scholar]
  78. SAUTTER R. D., FLETCHER F. W., EMANUEL D. A., LAWTON B. R., OLSEN T. G. COMPLETE RESOLUTION OF MASSIVE PULMONARY THROMBOEMBOLISM. JAMA. 1964 Sep 21;189:948–949. doi: 10.1001/jama.1964.03070120070022. [DOI] [PubMed] [Google Scholar]
  79. SCHEIDEGGER J. J. Une micro-méthode de l'immuno-electrophorèse. Int Arch Allergy Appl Immunol. 1955;7(2):103–110. [PubMed] [Google Scholar]
  80. Sasahara A. A., Cannilla J. E., Belko J. S., Morse R. L., Criss A. J. Urokinase therapy in clinical pulmonary embolism. A new thrombolytic agent. N Engl J Med. 1967 Nov 30;277(22):1168–1173. doi: 10.1056/NEJM196711302772203. [DOI] [PubMed] [Google Scholar]
  81. Schmutzler R. Thrombolytic treatment of acute peripheral arterial and venous occlusions. Angiologica. 1968;5(2):119–129. [PubMed] [Google Scholar]
  82. Schoop W., Martin M., Zeitler E. Beseitigung alter Arterienverschlüsse durch intravenöse Streptokinase-Infusion. Dtsch Med Wochenschr. 1968 Nov 29;93(48):2321–2324. doi: 10.1055/s-0028-1110933. [DOI] [PubMed] [Google Scholar]
  83. Semar M., Skoza L., Johnson A. J. Partial purification and properties of a plasminogen activator from human erythrocytes. J Clin Invest. 1969 Oct;48(10):1777–1785. doi: 10.1172/JCI106144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Svärd P. O. The effect of an enzyme preparation from Aspergillus oryzae on the aggregation of rabbit platelets in vitro. Scand J Haematol. 1966;3(4):277–289. doi: 10.1111/j.1600-0609.1966.tb02372.x. [DOI] [PubMed] [Google Scholar]
  85. Tow D. E., Wagner H. N., Jr, Holmes R. A. Urokinase in pulnonary embolism. N Engl J Med. 1967 Nov 30;277(22):1161–1167. doi: 10.1056/NEJM196711302772202. [DOI] [PubMed] [Google Scholar]
  86. VERSTRAETE M., AMERY A., VERMYLEN J. Feasibility of adequate thrombolytic therapy with streptokinase in peripheral arterial occlusions. I. Clinical and arteriographic results. Br Med J. 1963 Jun 8;1(5344):1499–1504. doi: 10.1136/bmj.1.5344.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. VON KAULLA K. N., SCHULTZ R. L. Methods for the evaluation of human fibrinolysis; studies with two combined technics. Am J Clin Pathol. 1958 Feb;29(2):104–112. doi: 10.1093/ajcp/29.2.104. [DOI] [PubMed] [Google Scholar]
  88. WINCKELMANN G., HIEMEYER V., WEISSLEDER H., SCHOOP W. DIE THROMBOLYTISCHE BEHANDLUNG MIT STEPTOKINASE BEI AKUTEN ARTERIELLEN VERSCHLUSSKRANKHEITEN. Dtsch Med Wochenschr. 1963 Nov 29;88:2331–2335. doi: 10.1055/s-0028-1112362. [DOI] [PubMed] [Google Scholar]
  89. Woodfield D. G., Cole S. K., Cash J. D. Impaired fibrinolytic response to exercise stress in normal pregnancy. Its possible role in the development of Shwartzman-type reactions. Am J Obstet Gynecol. 1968 Oct 1;102(3):440–446. doi: 10.1016/0002-9378(68)90017-3. [DOI] [PubMed] [Google Scholar]
  90. Zohairy A. F. Prevention of regurgitation during induction of anaesthesia with a cuffed oesophageal catheter. Br Med J. 1967 Mar 4;1(5539):545–546. doi: 10.1136/bmj.1.5539.545. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES